Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
PhenoMiner Database Result        View data table  |  Download data table  |  View compact data table        


Generate Chart For    
    (Chart displayed below)
Rat Strains

{{sample.term}}
Measurement Methods

{{method.term}}
Age

{{ageRange}}
Experimental Conditions

     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View compact data table
Study IDStudyExperiment NameExperiment NotesStrain Ont IDStrainSexAge# of AnimalsSample NotesClinical Measurement Ont IDPhenotypeFormulaClinical Measurement NotesAverage TypeValueUnitsSEMSDMethod Ont IDMethodMethod SiteMethod DurationMethod NotesPost Insult TypePost Insult Time ValuePost Insult Time UnitConditionsRecord IDCondition 1Condition 2aCondition 2bCondition 3
1096Dutil J, et al., Physiol Genomics 2005 Mar 1;.vasoconstriction traitRS:0000817SS/Jrmale98 days12CMO:0001656receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio34.85%2.9410.1845MMO:0000207tissue force analysis utilizing a force transducer0.0isometric force transducerKreb's solution perfusate then angiotensin II (0.3~300 umol/l) 69065Kreb's solution perfusateangiotensin II (0.3~300 umol/l)
1096Dutil J, et al., Physiol Genomics 2005 Mar 1;.vasoconstriction traitRS:0000817SS/Jrmale98 days12CMO:0001658logarithm of the concentration of angiotensin II at which the force of blood vessel contraction is half the maximum value (Log EC50)-8.220.260.9007MMO:0000207tissue force analysis utilizing a force transducer0.0isometric force transducerKreb's solution perfusate then angiotensin II (0.3~300 umol/l) 69067Kreb's solution perfusateangiotensin II (0.3~300 umol/l)
1096Dutil J, et al., Physiol Genomics 2005 Mar 1;.vasoconstriction traitRS:0000817SS/Jrmale98 days12CMO:0000716blood vessel contractile force measurement1.59g0.110.3811MMO:0000207tissue force analysis utilizing a force transducer0.0Kreb's solution perfusate then potassium chloride solution (40 mmol/l) 69048Kreb's solution perfusatepotassium chloride solution (40 mmol/l)
1096Dutil J, et al., Physiol Genomics 2005 Mar 1;.vasoconstriction traitRS:0000817SS/Jrmale98 days12CMO:0000716blood vessel contractile force measurement1.39g0.060.2078MMO:0000207tissue force analysis utilizing a force transducer0.0isometric force transducerKreb's solution perfusate then potassium chloride solution (40 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) 69050Kreb's solution perfusatepotassium chloride solution (40 mmol/l) NG-nitroarginine methyl ester (100 umol/l)
1096Dutil J, et al., Physiol Genomics 2005 Mar 1;.vasoconstriction traitRS:0000817SS/Jrmale98 days12CMO:0001656receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio104.06%4.716.2813MMO:0000207tissue force analysis utilizing a force transducer0.0isometric force transducerKreb's solution perfusate then phenylephrine (1~100 mmol/l) 69052Kreb's solution perfusatephenylephrine (1~100 mmol/l)
1096Dutil J, et al., Physiol Genomics 2005 Mar 1;.vasoconstriction traitRS:0000817SS/Jrmale98 days12CMO:0000722logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50)EC50 value is probably moles/liter-7.260.060.2078MMO:0000207tissue force analysis utilizing a force transducer0.0isometric force transducerKreb's solution perfusate then phenylephrine (1~100 mmol/l) 69054Kreb's solution perfusatephenylephrine (1~100 mmol/l)
1096Dutil J, et al., Physiol Genomics 2005 Mar 1;.vasoconstriction traitRS:0000817SS/Jrmale98 days12CMO:0001656receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio141.72%7.7326.7775MMO:0000207tissue force analysis utilizing a force transducer0.0isometric force transducerKreb's solution perfusate then phenylephrine (1~100 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) 69056Kreb's solution perfusatephenylephrine (1~100 mmol/l) NG-nitroarginine methyl ester (100 umol/l)
1096Dutil J, et al., Physiol Genomics 2005 Mar 1;.vasoconstriction traitRS:0000817SS/Jrmale98 days12CMO:0000722logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50)EC50 value is probably moles/liter-7.60.050.1732MMO:0000207tissue force analysis utilizing a force transducer0.0isometric force transducerKreb's solution perfusate then phenylephrine (1~100 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) 69058Kreb's solution perfusatephenylephrine (1~100 mmol/l) NG-nitroarginine methyl ester (100 umol/l)
1096Dutil J, et al., Physiol Genomics 2005 Mar 1;.vasoconstriction traitRS:0000817SS/Jrmale98 days12CMO:0001656receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio50.61%5.2918.3251MMO:0000207tissue force analysis utilizing a force transducer0.0isometric force transducerKreb's solution perfusate then angiotensin II (0.3~300 umol/l) and NG-nitroarginine methyl ester (100 umol/l) 69069Kreb's solution perfusateangiotensin II (0.3~300 umol/l) NG-nitroarginine methyl ester (100 umol/l)
1096Dutil J, et al., Physiol Genomics 2005 Mar 1;.vasoconstriction traitRS:0000817SS/Jrmale98 days12CMO:0001658logarithm of the concentration of angiotensin II at which the force of blood vessel contraction is half the maximum value (Log EC50)-7.920.361.2471MMO:0000207tissue force analysis utilizing a force transducer0.0isometric force transducerKreb's solution perfusate then angiotensin II (0.3~300 umol/l) then NG-nitroarginine methyl ester (100 umol/l) 69071Kreb's solution perfusateangiotensin II (0.3~300 umol/l) NG-nitroarginine methyl ester (100 umol/l)